Leptomeningeal disease (LMD) remains one of the most challenging diagnoses in neuro-oncology. MRI returns normal or ...
Delve Bio announces data showing Delve Detect enables neurologists to treat CNS infections when conventional testing fails at AAN Annual Meeting ...
The term signe de cils was introduced in the late 19th century and is attributed to Achille Souques, one of the most ...
Roche announced that its Elecsys Neurofilament Light Chain (NfL) test has received CE mark approval for the detection of neuroinflammation in patients diagnosed with relapsing remitting multiple ...
A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before ...
In a first-of-its-kind for the Karnataka region and among only the 2nd and 3rd such cases treated in India, Manipal Hospital ...
The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed with relapsing remitting multiple sclerosis.1This minimally invasive blood test enables grea ...
Emerging research has identified a potential biological connection between autism spectrum disorder and Alzheimer's disease, ...
Vero AI today reported Q1 2026 momentum with updates that enable audit teams to run testing across samples with step-level visibility ...
This case report describes a woman in her 60s diagnosed with primary vitreoretinal lymphoma (PVRL) with leptomeningeal ...
Kozhikode MCH's microbiology lab now offers PCR tests for amoebic fever, enhancing rapid diagnosis and treatment of deadly infections.
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...